HealthWarehouse.com, Inc. · OTC:HEWA
HealthWarehouse.com — Investor Presentation (March 2013)
19 slides from HealthWarehouse.com's investor presentation, Mar 19, 2013
Slide 1: Investor Presentation: Financial results through Q2 2012
Investor Presentation Financial results through Q2 2012 March 19, 2013
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation may contain forward - looking statements regarding future events or the future financial and operational performance of HealthWarehouse.com. Words such as “targets,” “expects,” “believes,” “anticipates,” “intends,” “may,” “will,” “plan,” “continue,” “forecast,
Slide 3: Introduction | Company Details
Introduction | Company Details ▪ Founded: August 2007 ▪ Headquarters: Florence, KY ▪ Stock Symbol: HEWA ▪ Employees: 50 ▪ Licenses: 50 States + DC ▪ Certifications: DEA ▪ Awards: 2
Slide 4: Industry Trends | Current Landscape
Industry Trends | Current Landscape Retail Mail - Order Prescriptions OTC Business to Business Only 3
Slide 5: Industry Trends | Current Landscape (continued)
Industry Trends | Current Landscape (continued) Pharmacy ℞ Sales 1 Internet ℞ Cash ℞ 3rd Party Generic ℞ Walgreens $46,700 1% 3% 96% 74% CVS Caremark 40,700 1% 1% 98% 76% Rite Aid 17,800 0% 2% 97% 76% Walmart 15,900 2% 20% 70% 65% Kroger 7,200 1% 25% 65% 50% Safeway 3,900 1% 10% 80% 50% Target 3,400
Slide 6: Industry Trends | Name-Brand Medications Moving to Generics
Industry Trends | Name - Brand Medications Moving to Generics Approximately $212 billion in name - brand medications will have become generic by 2015 Lipitor ®(1) Zyprexa ® Levaquin ® Effexor XR ® Flomax ® Aricept ® Cozaar ® Hyzaar ® Lovenox ® Abilify ® Prevacid ® Topamax ® Valtrex ® Adderall XR ® P
Slide 7: Industry Trends | Lipitor Case Study
Industry Trends | Lipitor Case Study Lipitor once sold for $150… …generic version now sells for $14 at HealthWarehouse ▪ Rent ▪ Inventory ▪ Employees ▪ $7 million to open ▪ 10 mile radius ▪ No significant increase in overhead to sell nationwide 6
Slide 8: Industry Trends | Change in Retail Pharmacy
Industry Trends | Change in Retail Pharmacy Pharmacies have shifted a significant portion of their revenue stream away from prescription medications Beer & Wine Cafés Groceries 7
Slide 9: The ACA and Expansion of HealthWarehouse's Addressable Market
Industry Trends | The ACA and Expansion of HealthWarehouse’s Addressable Market A McKinsey survey estimates that approximately 30% of employers are expected to drop insurance when the ACA takes full effect Source: US Census, McKinsey & Company Note: 1. The estimates by type of coverage are not mutua
Slide 10: Corporate Overview | Sources of Customer Acquisition
Corporate Overview | Sources of Customer Acquisition Individual Search Engines Primary Care Clinic Groups Group Insurance / Employers Social Media 9
Slide 11: PBM Partners | Signed Group Contracts
PBM Partners | Signed Group Contracts Group Total Lives 3 mm 1 mm 1 mm 16 mm 35 mm 56 mm Potential Revenue $120 mm $40 mm $40 mm $640 mm $1.4 bn $2.2 bn POTENTIAL: 56 million lives / $2.2bn in revenue 1 Note: 1. Potential revenue is calculated by taking 10pct of the total lives, multiplied by $400 o
Slide 12: Corporate Overview | Simplifying the Channel
Corporate Overview | Simplifying the Channel Cost paid by Consumer, Employer, Insurance Current Supply Chain HealthWarehouse Model Consumer Manufacturer Savings to Consumer, Employer, Insurance Manufacturer Consumer Wholesaler Distributor Pharmacy 11
Slide 13: Corporate Overview | Improving Efficiency and Purchasing Power
Corporate Overview | Improving Efficiency and Purchasing Power HealthWarehouse has recently begun developing its business - to - business division ("B2B"), which will drive further growth and allow for better purchasing power, resulting in improved margins on the direct to consumer division Manufact
Slide 14: Corporate Overview | Sample Cost Savings – Cash Price
Corporate Overview | Sample Cost Savings – Cash Price Drug QTY HW CVS Walgreens Actos 15mg 30 $178.00 $197.49 $203.49 Amlodipine 2.5mg 30 $3.50 $38.84 $41.49 Atorvastatin 10mg 30 $14.00 $137.49 $113.49 Benicar 5mg 30 $79.00 $85.51 $92.19 Diovan 40mg 30 $85.00 $93.11 $113.49 Simvastatin 40mg 30 $3.50
Slide 15: Growth Strategy | Current Opportunities
Growth Strategy | Current Opportunities HealthWarehouse is a disruptive business model that is poised to benefit from changing market dynamics within the prescription medication industry ▪ Disruptive business model ▪ Eliminate inefficiencies in drug distribution ▪ Provide consumers and employers dru
Slide 16: Financial Summary | Annual Financial Results
Financial Summary | Annual Financial Results USD 2008 2009 2010 2011 Revenue $1,270,527 $3,783,542 $5,691,765 $10,363,293 Gross Profit 299,900 1,148,284 $2,241,744 $4,517,768 Gross Margin (%) 23.6 30.4 39.4 44.6 Net Income ($667,301) ($2,439,502) ($3,691,674) ($5,712,199) 15
Slide 17: Financial Summary | Quarterly Financial Results
Financial Summary | Quarterly Financial Results USD Q1 2011 Q2 2011 Q3 2011 Q1 2012 Q2 2012 Revenue $2,284,552 $2,519,721 $2,783,240 $3,156,250 $2,997,326 Gross Profit $986,409 $1,115,529 $1,237,270 $1,438,195 $1,481,718 Gross Margin (%) 43.2 44.3 44.5 45.6 49.4 Net Income ($1,071,279) ($1,161,094)
Slide 18: Financial Summary | Prescription Growth – New and Refills
Financial Summary | Prescription Growth – New and Refills Growth in refills highlights stickiness of patient base 17 Prolonged release of 10 - K required substantial use of funds Marketing activity ceases in June 2012
Slide 19: Thank You
Thank You 7107 Industrial Rd Florence, KY 41042 TEL: 1 - 800 - 748 - 7001 http://www.HealthWarehouse.com 18
HealthWarehouse.com — Investor Presentation (March 2013) on 6ix